Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)6.99
  • Today's Change-0.05 / -0.71%
  • Shares traded1.95m
  • 1 Year change+6.88%
  • Beta1.1630
Data delayed at least 15 minutes, as of Nov 14 2024 03:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue7396251,043
OPERATING EXPENSES
Cost of revenue total12814366
Selling, general and admin. expenses, total560620438
Depreciation/amortization------
Unusual expense(income)0.270.100.03
Other operating expenses, total10524233
Total operating expense1,3431,4921,060
Operating income(604)(867)(17)
Other, net(0.04)----
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(644)(894)(20)
Provision for income taxes1.43047
Net income after taxes(646)(894)(67)
Minority interest147.132.13
Net income before extra. Items(631)(887)(65)
Total extraordinary items------
Net income(631)(887)(65)
Inc.avail. to common excl. extra. Items(631)(887)(65)
Inc.avail. to common incl. extra. Items(631)(887)(65)
EPS RECONCILIATION
Basic/primary weighted average shares1,6871,4801,366
Basic/primary eps excl. extra items(0.37)(0.6)(0.05)
Basic/primary eps incl. extra items(0.37)(0.6)(0.05)
Dilution adjustment------
Diluted weighted average shares1,6871,4801,366
Diluted eps excl. extra items(0.37)(0.6)(0.05)
Diluted eps incl. extra items(0.37)(0.6)(0.05)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental35172.64
SUPPLEMENTAL INCOME
Depreciation, supplemental825728
Total special items0.270.100.03
NORMALISED INCOME
Normalized income before taxes(644)(894)(20)
Effect of special items on income taxes0.0900.01
Income tax excluding impact of special items1.52047
Normalized income after tax(645)(894)(67)
Normalized income avail. to common(631)(886)(65)
Basic normalized EPS(0.37)(0.6)(0.05)
Diluted normalized EPS(0.37)(0.6)(0.05)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.